05/06/2020: Lab Advisory: CMS Issues Updated COVID-19 Frequently Asked Questions about Medicare Fee-for-Service Billing
Audience: Clinical Laboratory Professionals
Level: Laboratory Advisory
CMS Issues Updated COVID-19 Frequently Asked Questions about Medicare Fee-for-Service Billing
CMS recently issued updated frequently asked questions (FAQs) about Medicare fee-for-service billing during the COVID-19 public health emergency (PHE). The updated FAQs supplement the previously released 1135 Waiver FAQs, and Without 1135 Waiver FAQs related to waivers or modifications under section 1135 of the Social Security Act. The policies outlined in the FAQs are effective for the duration of the PHE unless superseded by future legislation.
Online Resources:
Laboratory Outreach Communication System | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)